LivaNova PLC
NASDAQ:LIVN
| Market Cap (Intraday) | 3.81B |
| Current PE | N/A |
| Forward PE | 63.13 |
| 2yr Forward PE | 37.88 |
| 10-Day MA | $74.17 |
| 50-Day MA | $68.19 |
| 200-Day MA | $55.02 |
LivaNova Plc Stock, NASDAQ:LIVN
20 Eastbourne Terrace, 20 Eastbourne Terrace, London, Greater London W2 6LG
United Kingdom
Phone: +44.203.325.0660
Number of Employees: 4000
Description
LivaNova Plc is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the following segments: Cardiovascular and Neuromodulation. The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and advanced circulatory support products. The Neuromodulation segment designs and markets NM-based medical devices for the treatment of epilepsy, depression, and obstructive sleep apnea. The company was founded on February 20, 2015 and is headquartered in London, the United Kingdom.